Idera Pharmaceuticals Total Assets

Idera Pharmaceuticals (IDRA) currently reports a total assets of $78M as of March 2023. That compares with $30M in the prior-year period — up 160.5% year over year. Use the charts on this page to explore Idera Pharmaceuticals's total assets history and peer comparisons.

Idera Pharmaceuticals's total assets increased from $30M to $78M — a 160.5% year-over-year increase (period ending March 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Idera Pharmaceuticals reported $78M in total assets as of March 2023. That compares with $30M in the prior-year period — up 160.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total assets of $78M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Idera Pharmaceuticals, and consider following IDRA for alerts when major investors trade the stock.

Idera Pharmaceuticals is classified in the Healthcare sector. On total assets, it currently shows $78M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing IDRA with unrelated industries.